phase 2, 0 NCT04787211
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) vs. placebo
COVID-19 mild to moderate
CORIMUNO-ANA-1, 2021 NCT04341584
anakinra vs. control
COVID-19 mild to moderate
CORIMUNO-NIVO, 0 NCT04343144
anti-PD-1 antibody vs. standard of care
COVID-19 mild to moderate
X-COVID-19, 2021 NCT04366960
anticoagulant vs. control
COVID-19 mild to moderate
ATTACC, ACTIV-4a, and REMAP-CAP (noncritically ill patients), 2021 NCT02735707
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID-19 mild to moderate
NCT04446377, 0 NCT04446377
Apilimod vs. standard of care
COVID-19 mild to moderate
NCT04613271, 0 NCT04613271
azithromycin vs. azithromycin
COVID-19 mild to moderate
COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 NCT04322123
azithromycin vs. standard of care
COVID-19 mild to moderate
Espitia-Hernandez, 2020
azithromycin vs. standard of care
COVID-19 mild to moderate
Rashad A (AZI vs SoC), 2021
azithromycin vs. standard of care
COVID-19 mild to moderate
Coalition Covid-19 Brazil I (Cavalcanti) - HCQ AZI, 2020 NCT04322123
azithromycin plus hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Ren, 2020 ChiCTR2000029853
azvudine vs. antiviral and associated therapy
COVID-19 mild to moderate
Rodriguez-Garcia, 2020 EUPAS34966
baricitinib vs. standard of care
COVID-19 mild to moderate
Cantini, 2020
baricitinib vs. standard of care
COVID-19 mild to moderate
Cantini, 2020
baricitinib vs. standard of care
COVID-19 mild to moderate
CORIMMUNO-BEVA, 0 NCT04344782
bevacizumab vs. standard of care
COVID-19 mild to moderate
Li T, 2020 NCT04273763
bromhexine vs. standard of care
COVID-19 mild to moderate
CLOCC, 0 NCT04338906
camostat mesilate vs. placebo
COVID-19 mild to moderate
Crippa (CANDIDATE), 2021 NCT04467918
Cannabidiol vs. placebo
COVID-19 mild to moderate
Suzuki, 2021
casirivimab/imdevimab (Ronapreve) vs. control
COVID-19 mild to moderate
Somersan-Karakaya (Cohort 1, Cohort 1A; Combined doses), 2021 NCT04426695
casirivimab/imdevimab (Ronapreve) vs. placebo
COVID-19 mild to moderate
NCT04342650, 2020 NCT04342650
chloroquine vs. placebo
COVID-19 mild to moderate
Thakar, 2021
chloroquine vs. standard of care
COVID-19 mild to moderate
CloroCOVID19II, 0 NCT04342650
chloroquine and derivatives vs. placebo
COVID-19 mild to moderate
Asan Medical Center (chloroquine), 0 NCT04307693
chloroquine and derivatives vs. standard of care
COVID-19 mild to moderate
Rashad (CLARI vs SoC), 2021
clarithromycine vs. standard of care
COVID-19 mild to moderate
Yamamoto (CAME COVID), 2021 jRCTs071210011
clarithromycine vs. standard of care
COVID-19 mild to moderate
COL-COVID (Pascual-Figal), 2021 NCT04350320
colchicine vs. standard of care
COVID-19 mild to moderate
Libster, 2020 NCT04479163
convalescent plasma treatment vs. placebo
COVID-19 mild to moderate
CORIPLASM, 0 NCT04345991
convalescent plasma treatment vs. standard of care
COVID-19 mild to moderate
PLACID, 2020 CTRI/2020/04/024775
convalescent plasma treatment vs. standard of care
COVID-19 mild to moderate
Li (Methylprednisolone, Shanghai cohort), 2020
corticosteroids vs. control
COVID-19 mild to moderate
Majmundar, 2020
corticosteroids vs. control
COVID-19 mild to moderate
Lopes (BRACE CORONA), 2021 NCT04364893
discontinuation of ACEI/ARB vs. continuation of ACEI/ARB
COVID-19 mild to moderate
Spoorthi, 2020
doxycycline vs. placebo
COVID-19 mild to moderate
NCT04444700, 0 NCT04444700
enoxaparin vs. standard of care
COVID-19 mild to moderate
Mukae - Phase 2a, 2022 jRCT2031210350
Ensitrelvir (XOCOVA) vs. placebo
COVID-19 mild to moderate
NCT04613271, 0 NCT04613271
favipiravir vs. azithromycin
COVID-19 mild to moderate
Dabbous, 2021 NCT04351295
favipiravir vs. chloroquine
COVID-19 mild to moderate
CTRI/2020/06/025957, 0 CTRI/2020/06/025957
favipiravir vs. favipiravir
COVID-19 mild to moderate
IRCT20201005048936N1, 0 IRCT20201005048936N1
favipiravir vs. hydroxychloroquine
COVID-19 mild to moderate
IRCT20151227025726N14 // U07, 0 IRCT20151227025726N1
favipiravir vs. lopinavir/ritonavir
COVID-19 mild to moderate
Solaymani-Dodaran, 2021 IRCT20200318046812N1
favipiravir vs. lopinavir/ritonavir
COVID-19 mild to moderate
Hassaniazad, 2020 IRCT20200506047323N3
favipiravir vs. lopinavir/ritonavir plus interferon ß-1a
COVID-19 mild to moderate
NCT04336904, 0 NCT04336904
favipiravir vs. placebo
COVID-19 mild to moderate
Holubar M, 2021 NCT04346628
favipiravir vs. placebo
COVID-19 mild to moderate
NCT04600895, 0 NCT04600895
favipiravir vs. placebo
COVID-19 mild to moderate
NCT04464408, 0 NCT04464408
favipiravir vs. placebo
COVID-19 mild to moderate
Shenoy S, 2021 NCT04529499
favipiravir vs. placebo
COVID-19 mild to moderate
EUCTR2020-001608-40-DE, 0 EUCTR2020-001608-40-
favipiravir vs. placebo
COVID-19 mild to moderate
Shinkai, 2021 JapicCTI-205238
favipiravir vs. placebo
COVID-19 mild to moderate
Dabbous HM, 2020 NCT04349241
favipiravir vs. standard of care
COVID-19 mild to moderate
FACCT Trial, 2021 NCT04392973
favipiravir vs. standard of care
COVID-19 mild to moderate
Udwadia, 2020 CTRI/2020/05/025114
favipiravir vs. standard of care
COVID-19 mild to moderate
AVIFAVIR, 2020 NCT04434248
favipiravir vs. standard of care
COVID-19 mild to moderate
NCT04542694, 2020 NCT04542694
favipiravir vs. standard of care
COVID-19 mild to moderate
GETAFIX, 2020 ISRCTN31062548
favipiravir vs. standard of care
COVID-19 mild to moderate
NCT04600999, 0 NCT04600999
favipiravir vs. standard of care
COVID-19 mild to moderate
Ruzhentsova T, 2020 NCT04501783
favipiravir vs. standard of care
COVID-19 mild to moderate
Khamis, 2020
favipiravir plus interferon vs. standard of care
COVID-19 mild to moderate
EUCTR2020-002299-11, 0 EUCTR2020-002299-11
fluvoxamine vs. placebo
COVID-19 mild to moderate
NCT04668950, 0 NCT04668950
fluvoxamine vs. placebo
COVID-19 mild to moderate
Vergis, 2021 NCT04581954
fostamatinib vs. standard of care
COVID-19 mild to moderate
RAPID (Sholzberg), 2021 NCT04362085
heparin at therapeutic dose vs. standard of care
COVID-19 mild to moderate
COVIT-TRIAL, 2022 NCT04344041
hight dose vitamin D vs. Vitamin D
COVID-19 mild to moderate
Min, 2020
hydroxychloroquine vs. control
COVID-19 mild to moderate
Fteiha, 2020
hydroxychloroquine vs. control
COVID-19 mild to moderate
NCT04333654, 2020 NCT04333654
hydroxychloroquine vs. placebo
COVID-19 mild to moderate
COV-HCQ, 2020 NCT04342221
hydroxychloroquine vs. placebo
COVID-19 mild to moderate
Dubee, 2021
hydroxychloroquine vs. placebo
COVID-19 mild to moderate
HC-nCoV (Shanghai), 2020 NCT04261517
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Zhaowei Chen, 2020 ChiCTR2000029559
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Coalition Covid-19 Brazil I (Cavalcanti)-Hydroxychloroquine, 2020 NCT04322123
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
FACCT Trial, 2021 NCT04392973
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Kamran, 2020 NCT04491994
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
COVIDOC, 0 NCT04345861
hydroxychloroquine plus macrolides vs. chloroquine and derivatives
COVID-19 mild to moderate
AZIQUINE-ICU (A plus HCQ), 0 NCT04339816
hydroxychloroquine plus macrolides vs. placebo
COVID-19 mild to moderate
Covid-19 HUF, 2021 NCT04346147
imatinib vs. lopinavir/ritonavir plus chloroquine
COVID-19 mild to moderate
Ravichandran, 2020
Indomethacin vs. paracetamol
COVID-19 mild to moderate
Ravichandran, 2021 CTRI/2021/05/033544
Indomethacin vs. paracetamol
COVID-19 mild to moderate
NCT04343768, 0 NCT04343768
interferon vs. interferon
COVID-19 mild to moderate
Hassaniazad, 2020 IRCT20200506047323N3
interferon vs. lopinavir/ritonavir plus interferon ß-1a
COVID-19 mild to moderate
COVID-Lambda, 0 NCT04331899
interferon vs. standard of care
COVID-19 mild to moderate
Fu, 2020 ChiCTR2000030262
interferon / TFF2 vs. standard of care
COVID-19 mild to moderate
Abd-Elsalam, 2021 NCT04403555
ivermectin vs. control
COVID-19 mild to moderate
Mayer, 2022
ivermectin vs. control
COVID-19 mild to moderate
Babalola, 2021
ivermectin vs. lopinavir/ritonavir
COVID-19 mild to moderate
SINZ-COVID-PK, 2020 NCT04472585
ivermectin vs. placebo
COVID-19 mild to moderate
Ahmed, 2020
ivermectin vs. placebo
COVID-19 mild to moderate
Chaccour, 2020 NCT04390022
ivermectin vs. placebo
COVID-19 mild to moderate
Spoorthi, 2020
ivermectin vs. placebo
COVID-19 mild to moderate
Kirti, 2021 CTRI/2020/08/027225
ivermectin vs. placebo
COVID-19 mild to moderate
RIVET-COV (Mohan) (12mg and 24mg), 2021 CTRI/2020/06/026001
ivermectin vs. placebo
COVID-19 mild to moderate
Glorial F, 2020 NCT04343092
ivermectin vs. standard of care
COVID-19 mild to moderate
IFORS (Pott-Junior), 2020 NCT04431466
ivermectin vs. standard of care
COVID-19 mild to moderate
Shahbaznejad, 2020 IRCT20111224008507N3
ivermectin vs. standard of care
COVID-19 mild to moderate
Chachar, 2020 NCT04739410
ivermectin vs. standard of care
COVID-19 mild to moderate
Espitia-Hernandez, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Khan, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Soto-Becerra, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Bukhari, 2021 NCT04392713
ivermectin vs. standard of care
COVID-19 mild to moderate
Nasir, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Krolewiecki, 2020 NCT004381884
ivermectin vs. standard of care
COVID-19 mild to moderate
I-TECH (Lim), 2022 NCT04920942
ivermectin vs. standard of care
COVID-19 mild to moderate
NCT04523831 (Mahmud), 2020 NCT04523831
ivermectin plus doxycycline vs. standard of care
COVID-19 mild to moderate
LIVE-AIR (Temesgen), 2021 NCT04351152
lenzilumab vs. placebo
COVID-19 mild to moderate
NCT04343651, 0 NCT04343651
leronlimab vs. placebo
COVID-19 mild to moderate
Asan Medical Center (lopinavir/ritonavir), 0 NCT04307693
lopinavir/ritonavir vs. standard of care
COVID-19 mild to moderate
ELACOI (lopinavir/ritonavir), 2020 NCT04252885
lopinavir/ritonavir vs. standard of care
COVID-19 mild to moderate
Hung et al., 2020 NCT04276688
lopinavir/ritonavir, ribavirin and interferon beta-1b vs. lopinavir/ritonavir
COVID-19 mild to moderate
Pupim, 2021
mavrilimumab vs. placebo
COVID-19 mild to moderate
Rocco, 2020 NCT04552483
nitazoxanide vs. placebo
COVID-19 mild to moderate
Silva, 2021 NCT04463264
nitazoxanide vs. placebo
COVID-19 mild to moderate
Fontanesi, 2021 NCT04348409
nitazoxanide vs. placebo
COVID-19 mild to moderate
NOCOVID, 0 NCT04337918
nitric oxide (gas Inhalation or releasing solution) vs. standard of care
COVID-19 mild to moderate
Guzman-Esquivel, 2022
non-steroidal anti-inflammatory drugs vs. placebo
COVID-19 mild to moderate
Jagannathan, 2020 NCT04331899
peginterferon vs. placebo
COVID-19 mild to moderate
Pandit, 2021 CTRI/2020/06/026087
pegylated interferon-α2b vs. standard of care
COVID-19 mild to moderate
Shashi Bhushan, 2021 CTRI/2020/12/029855
pegylated interferon-α2b vs. standard of care
COVID-19 mild to moderate
Lattmann, 2021 CTRI/2020/10/028423
PNB001 vs. standard of care
COVID-19 mild to moderate
Ghandehari, 2020 NCT04365127
progesterone vs. standard of care
COVID-19 mild to moderate
GS-US-540-5773 (Goldman), 2020 NCT04292899
remdesivir vs. remdesivir
COVID-19 mild to moderate
GS-US-540-5774, 10 days, 2020 NCT04292730
remdesivir vs. standard of care
COVID-19 mild to moderate
GS-US-540-5774, 5 days, 2020 NCT04292730
remdesivir vs. standard of care
COVID-19 mild to moderate
Vergis, 2021 NCT04581954
ruxolitinib vs. standard of care
COVID-19 mild to moderate
VERU-111, 2022 NCT04842747
sabizabulin vs. placebo
COVID-19 mild to moderate
Nourian A, 2020 IRCT20100228003449
sofosbuvir and ledipasvir vs. standard of care
COVID-19 mild to moderate
Capra, 2020
tocilizumab vs. control
COVID-19 mild to moderate
NCT04345445, 0 NCT04345445
tocilizumab vs. corticosteroids
COVID-19 mild to moderate
Murugesan, 2022
tofacitinib vs. standard of care
COVID-19 mild to moderate
CTRI/2020/06/025957, 0 CTRI/2020/06/025957
umifenovir (arbidol) vs. favipiravir
COVID-19 mild to moderate
ELACOI (Lopinavir/ritonavir), 2020 NCT04252885
umifenovir (arbidol) vs. lopinavir/ritonavir
COVID-19 mild to moderate
Yethindra, 2020 None
umifenovir (arbidol) vs. standard of care
COVID-19 mild to moderate
Rastogi, 2020 NCT04459247
Vitamin D vs. placebo
COVID-19 mild to moderate
Espitia-Hernandez, 2020
Vitamin D vs. standard of care
COVID-19 mild to moderate
POLYCOR phase IIb (Gaborit), 2021 NCT04453384
XAV-19 vs. placebo
COVID-19 mild to moderate